Azitra Inc (AZTR)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $3.69M
Last updated: Nov 17, 2026 at 11:03 AM ET
Azitra Inc (AZTR) Competitors
The companies most similar to Azitra are Dermata Therapeutics (DRMA), Traws Pharma (TRAW) and XTL Biopharmaceuticals Ltd ADR (XTLB). By market cap, Azitra ranks 9th of the 13 companies on this page; Theriva Biologics (TOVX) is the largest at $6.61M.
Peer Comparison
AZTR's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Azitra (AZTR) | $3.69M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Dermata Therapeutics Inc (DRMA) | $3.06M | N/A | 41.3x | 0.0% | N/A | 0.0% | 0.00% |
| Traws Pharma Inc (TRAW) | $3.86M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | $3.93M | N/A | 4.0x | 0.0% | N/A | 0.0% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Theriva Biologics Inc. (TOVX) | $6.61M | N/A | 21.5x | 0.0% | -52.3% | 0.0% | 0.00% |
| Aprea Therapeutics Inc (APRE) | $5.91M | N/A | N/A | 0.0% | N/A | -98.4% | 0.00% |
| BioRestorative Therapies Inc (BRTX) | $2.06M | N/A | 70.3x | 0.0% | -289.9% | -7.3% | 0.00% |
| GRI Bio Inc. (GRI) | $3.72M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Skye Bioscience, Inc. Common Stock (SKYE) | $4.83M | N/A | N/A | 0.0% | -3685.3% | 0.0% | 0.00% |
| Creative Medical Technology Holdings Inc (CELZ) | $4.01M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $3.82M | N/A | 31.4x | 0.0% | -289.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Azitra, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Dermata Therapeutics Inc (DRMA) | Dermata Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for dermatological conditions... | DRMA competitors |
| Traws Pharma Inc (TRAW) | Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. | TRAW competitors |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment... | |
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| Theriva Biologics Inc. (TOVX) | Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. | TOVX competitors |
| Aprea Therapeutics Inc (APRE) | Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor... | APRE competitors |
| BioRestorative Therapies Inc (BRTX) | BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue... | BRTX competitors |
| GRI Bio Inc. (GRI) | GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology. | GRI competitors |
| Skye Bioscience, Inc. Common Stock (SKYE) | Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops... | SKYE competitors |
| Creative Medical Technology Holdings Inc (CELZ) | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics... | CELZ competitors |
Frequently Asked Questions About AZTR
Who are Azitra's main competitors?
The companies most similar to Azitra include Dermata Therapeutics (DRMA), Traws Pharma (TRAW), XTL Biopharmaceuticals Ltd ADR (XTLB), Bioatla (BCAB) and PharmaCyte Biotech (PMCB), listed from the closest match.
Who is Azitra's biggest competitor?
Theriva Biologics (TOVX) is the largest of the similar companies at $6.61M; Dermata Therapeutics (DRMA) is the closest match by business profile, size, sector and industry.
How does AZTR stock compare with its competitors?
AZTR's net margin is 0.0% against a peer median of 0.0%.
Which of Azitra's competitors pays a higher dividend?
Azitra pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Azitra bigger than its competitors?
No. Azitra is 9th by market cap among the 13 companies on this page; the largest is Theriva Biologics (TOVX) at $6.61M.
AZTR pages: Overview, Earnings, Forecast, Financials, Competitors